Yang Du

5.2k citations

128 papers · 3.7k indexed · 2 hit papers · h-index 30

Impact in

Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics
- Photoacoustic and Ultrasonic Imaging
- Characterization and Applications of Magnetic Nanoparticles

Papers in ⓘ

Biomedical Engineering 68
- Nanoplatforms for cancer theranostics 35
- Characterization and Applications of Magnetic Nanoparticles 16
- Photoacoustic and Ultrasonic Imaging 14
Biophysics 8

Co-authors: Jie Tian (61 shared papers)Chongwei Chi (12 shared papers)Qian Liang (10 shared papers)Jie Tian (7 shared papers)Xiaolong Liang (11 shared papers)Xiaoli Liu (2 shared papers)Xing‐Jie Liang (2 shared papers)Kun Wang (7 shared papers)
Journals: European Journal of Nuclear Medicine and Molecular Imaging (7 papers)Molecular Imaging and Biology (7 papers)IEEE Transactions on Biomedical Engineering (4 papers)Cancer Letters (3 papers)ACS Nano (3 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Yang Du

118 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

NIR-II light in clinical oncology: opportunities and challenges 2024 · 164 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature Reviews Clinical Oncology
2023 Nature Reviews Bioengineering

Peers

Countries citing papers authored by Yang Du

Since Specialization

Citations

This map shows the geographic impact of Yang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Du more than expected).

Fields of papers citing papers by Yang Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Du. The network helps show where Yang Du may publish in the future.

Co-authors

The 25 scholars most cited alongside Yang Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yang Du Line = papers co-authored together Yang Du links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology Theranostics ·Chongwei Chi, Yang Du, Jinzuo Ye, Deqiang Kou, Jingdan Qiu, Jiandong Wang, Jie Tian, Xiaohong Chen	2014	302
2	Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy Nano Letters ·Yang Du, Xiaoli Liu, Qian Liang, Xing‐Jie Liang, Jie Tian	2019	208
3	Ferrimagnetic Vortex Nanoring-Mediated Mild Magnetic Hyperthermia Imparts Potent Immunological Effect for Treating Cancer Metastasis ACS Nano ·Xiaoli Liu, Jianjun Zheng, Wei Sun, Xiao Zhao, Yao Li, Ningqiang Gong, Yanyun Wang, Xiaowei Ma, Tingbin Zhang, Lingyun Zhao, Yayi Hou, Zhibing Wu, Yang Du, Haiming Fan, Jie Tian, Xing‐Jie Liang	2019	202
4	DNA‐Nanostructure–Gold‐Nanorod Hybrids for Enhanced In Vivo Optoacoustic Imaging and Photothermal Therapy Advanced Materials ·Yang Du, Qiao Jiang, Nicolas Bézière, Linlin Song, Qian Zhang, Dong Peng, Chongwei Chi, Xin Yang, Hongbo Guo, Gaël Diot, Vasilis Ntziachristos, Baoquan Ding, Jie Tian	2016	190
5	Core–Shell Gold Nanorod@Metal–Organic Framework Nanoprobes for Multimodality Diagnosis of Glioma Advanced Materials ·Wenting Shang, Chaoting Zeng, Yang Du, Hui Hui, Xiao Liang, Chongwei Chi, Kun Wang, Zhongliang Wang, Jie Tian	2016	190
6	Asymmetric 3D Convolutional Neural Networks for action recognition Pattern Recognition ·Hao Yang, Chunfeng Yuan, Bing Li, Yang Du, Junliang Xing, Weiming Hu, Stephen J. Maybank	2018	167
7	NIR-II light in clinical oncology: opportunities and challenges Nature Reviews Clinical Oncology ·Zeyu Zhang, Yang Du, Xiaojing Shi, Kun Wang, Qiaojun Qu, Qian Liang, Xiaopeng Ma, Kunshan He, Chongwei Chi, Jianqiang Tang, Бо Лю, Jiafu Ji, Jun Wang, Jiahong Dong, Zhenhua Hu, Jie Tian Hit paper breakdown →	2024	164
8	A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence ACS Nano ·Tianjun Zhou, Xiaolong Liang, Peifeng Wang, Yueyang Hu, Yafei Qi, Yushen Jin, Yang Du, Chihua Fang, Jie Tian	2020	140
9	Fluorescence image-guided tumour surgery Nature Reviews Bioengineering ·Kun Wang, Yang Du, Zeyu Zhang, Kunshan He, Zhongquan Cheng, Lin Yin, Di Dong, Changjian Li, Wei Li, Zhenhua Hu, Chong Zhang, Hui Hui, Chongwei Chi, Jie Tian Hit paper breakdown →	2023	133
10	Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer Biomaterials ·Wei Sun, Yang Du, Xiaolong Liang, Chunyao Yu, Junjie Fang, Wei Lü, Xiuyu Guo, Jie Tian, Yinhua Jin, Jianjun Zheng	2019	122
11	Fast catalytic degradation of organic dye with air and MoO3:Ce nanofibers under room condition Applied Catalysis B: Environmental ·Wei Li, Shunbo Zhao, Bin Qi, Yang Du, Xiaohong Wang, Mingxin Huo	2009	103
12	rSNPBase: a database for curated regulatory SNPs Nucleic Acids Research ·Liyuan Guo, Yang Du, Suhua Chang, Kunlin Zhang, Jing Wang	2013	95
13	Cancer Diagnosis and Imaging-Guided Photothermal Therapy Using a Dual-Modality Nanoparticle ACS Applied Materials & Interfaces ·Chaoting Zeng, Wenting Shang, Xiaoyuan Liang, Xiao Liang, Qingshan Chen, Chongwei Chi, Yang Du, Chihua Fang, Jie Tian	2016	73
14	Radiomics analysis allows for precise prediction of epilepsy in patients with low-grade gliomas NeuroImage Clinical ·Zhenyu Liu, Yinyan Wang, Xing Liu, Yang Du, Zhenchao Tang, Kai Wang, Jingwei Wei, Di Dong, Yali Zang, Jianping Dai, Tao Jiang, Jie Tian	2018	65
15	Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments Cancer Letters ·Yang Du, Xiaolong Liang, Yuan Li, Ting Sun, Huadan Xue, Zhengyu Jin, Jie Tian	2017	62
16	Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-⁶⁴Cu/IRDye800CW Allows Improved Breast Tumor Targeted Imaging and Therapy Molecular Pharmaceutics ·Yang Du, Xiaolong Liang, Yuan Li, Ting Sun, Zhengyu Jin, Huadan Xue, Jie Tian	2017	62
17	EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer Nanoscale ·Yuan Li, Yang Du, Xiaolong Liang, Ting Sun, Huadan Xue, Jie Tian, Jin Zhengyu	2018	61
18	Mixed Metal Metal–Organic Frameworks Derived Carbon Supporting ZnFe₂O₄/C for High-Performance Magnetic Particle Imaging Nano Letters ·Zhenqi Jiang, Xiao Han, Yang Du, Yanying Li, Yong Li, Juan Li, Jie Tian, Aiguo Wu	2021	58
19	PD‐L1 Aptamer‐Functionalized Metal–Organic Framework Nanoparticles for Robust Photo‐Immunotherapy against Cancer with Enhanced Safety Angewandte Chemie International Edition ·Jingfang Zhang, Wenzhe Li, Yafei Qi, Guorong Wang, Lele Li, Zhengyu Jin, Jie Tian, Yang Du	2022	55
20	Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects Oncotarget ·Xiaohua Jia, Guowei Feng, Zhongliang Wang, Yang Du, Chen Shen, Hui Hui, Dong Peng, Zongjin Li, Deling Kong, Jie Tian	2016	48

About Yang Du

Yang Du is a scholar working on Biomedical Engineering, Biophysics, Biotechnology, Biomaterials and Oncology, having authored 128 papers that have together received 3.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (35 papers), Cancer Immunotherapy and Biomarkers (16 papers), Characterization and Applications of Magnetic Nanoparticles (16 papers), Photoacoustic and Ultrasonic Imaging (14 papers), Nanoparticle-Based Drug Delivery (13 papers), Geomagnetism and Paleomagnetism Studies (13 papers), Immunotherapy and Immune Responses (13 papers) and Optical Imaging and Spectroscopy Techniques (9 papers). The work is most often cited by research in Biomaterials (632 citations), Biomedical Engineering (2.1k citations), Radiology, Nuclear Medicine and Imaging (470 citations), Immunology (403 citations) and Oncology (497 citations). Yang Du has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jie Tian, Chongwei Chi, Qian Liang, Jie Tian, Xiaolong Liang, Xiaoli Liu, Xing‐Jie Liang, Kun Wang, Jinzuo Ye and Hui Hui. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Molecular Imaging and Biology, IEEE Transactions on Biomedical Engineering, Cancer Letters and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact